Browse the corpus

REFERENCES DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, “Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, Department of Health and Human Services,” February 12, 2013;1-267. Available at file://www.aidsinfo.nih.gov DHHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, “Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, Department of Health and Human Services,” August 11, 2011;1-268. Available at file://www.aidsinfo.nih.gov DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, "Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States," July 31, 2012. Available at file://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf Foster RH and Faulds D, “Abacavir,” Drugs, 1998, 55(5):729-36. [PubMed 9585869 ] Havlir DV and Lange JM, “New Antiretrovirals and New Combinations,” AIDS , 1998, 12(Suppl A):165-74. Kline MW, Blanchard S, Fletcher CV, et al, “A Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children With Human Immunodeficiency Virus Infection,” Pediatrics , 1999, 103(4):e47. Available at file://www.pediatrics.org/cgi/content/full/103/4/e47 [PubMed 10103339 ] Lucas A, Nolan D, and Mallal S, “HLA-B*5701 Screening for Susceptibility to Abacavir Hypersensitivity,” J Antimicrob Chemother , 2007, 59(4):591-3. [PubMed 17317695 ] Mallal S, Nolan D, Witt C, et al, “Association Between Presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and Hypersensitivity to HIV-1 Reverse-Transcriptase Inhibitor Abacavir,” Lancet , 2002, 359:727-32. [PubMed 11888582 ] Schmit JC and Weber B, “Recent Advances in Antiretroviral Therapy and HIV Infection Monitoring,” Intervirology , 1997, 40(5-6):304-21. [PubMed 9675636 ] “Three New Drugs for HIV Infection,” Med Lett Drugs Ther , 1998, 40(1041):114-6. [PubMed 9854567 ] Weverling GJ, Lange JM, Jurriaans S, et al, “Alternative Multidrug Regimen Provides Improved Suppression of HIV-1 Replication Over Triple Therapy,” AIDS , 1998, 12(11):F117-22. [PubMed 9708401 ] Topic 8993 Version 44.0

Schmit JC and Weber B, “Recent Advances in Antiretroviral Therapy and HIV Infection Monitoring,” Intervirology , 1997, 40(5-6):304-21. [PubMed 9675636 ] “Three New Drugs for HIV Infection,” Med Lett Drugs Ther , 1998, 40(1041):114-6. [PubMed 9854567 ] Weverling GJ, Lange JM, Jurriaans S, et al, “Alternative Multidrug Regimen Provides Improved Suppression of HIV-1 Replication Over Triple Therapy,” AIDS , 1998, 12(11):F117-22. [PubMed 9708401 ] Topic 8993 Version 44.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [0504-219.243.220.100-C38B34FA94-S244013.14]